Predictive Technology Group, Inc. (PRED)
|Net Income (ttm)||-68.15M|
|Trading Day||July 23|
|Day's Range||0.1549 - 0.1950|
|52-Week Range||0.0300 - 0.5600|
Shares of two companies that a short seller alleged were making fraudulent claims about tests for COVID-19 were suspended from trading by the Securities and Exchange Commission on Wednesday, as the regu...
Predictive Technology Group, Inc., together with its subsidiaries, develops and commercializes discoveries and technologies involved in novel molecular diagnostic, therapeutic, and human cellular and tissue-based products (HCT/Ps). It operates in two segments, Human Cellular and Tissues Products (HCT/Ps); and Diagnostics and Therapeutics. The company provides FertilityDX, a genetic testing service for couples experiencing infertility; ARTguide, a genetic test for women experiencing infertility because of endometriosis and other genetic conditio... [Read more...]
Research and Development in Biotechnology
|Stock Exchange |
|Ticker Symbol |
In 2020, PRED's revenue was $24.44 million, a decrease of -43.80% compared to the previous year's $43.49 million. Losses were -$85.90 million, 456.9% more than in 2019.